REGENERON PHARMACEUTICALS, INC. Insider Trading for January 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. for January 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 27 2021 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | M | 380.95 | 2,480 | 944,756 | 2,479 | |
Jan 27 2021 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 554.32 | 2,480 | 1,374,714 | 891 | 3.4 K to 891 (-73.57 %) |
Jan 27 2021 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Buy | M | 380.95 | 2,480 | 944,756 | 3,371 | 891 to 3.4 K (+278.34 %) |
Jan 05 2021 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | A | 482.68 | 3,613 | 1,743,923 | 3,613 | |
Jan 05 2021 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | A | 482.68 | 3,613 | 1,743,923 | 3,613 | |
Jan 05 2021 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Grant | A | 0.00 | 248 | 0 | 891 | 643 to 891 (+38.57 %) |
Jan 05 2021 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Grant | A | 0.00 | 248 | 0 | 891 | 643 to 891 (+38.57 %) |
Jan 05 2021 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | A | 482.68 | 3,613 | 1,743,923 | 3,613 | |
Jan 05 2021 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Grant | A | 0.00 | 248 | 0 | 54,663 | 54.4 K to 54.7 K (+0.46 %) |
Jan 05 2021 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | A | 482.68 | 3,613 | 1,743,923 | 3,613 | |
Jan 05 2021 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Grant | A | 0.00 | 248 | 0 | 54,663 | 54.4 K to 54.7 K (+0.46 %) |
Jan 05 2021 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Option Exercise | A | 482.68 | 3,613 | 1,743,923 | 3,613 | |
Jan 05 2021 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Grant | A | 0.00 | 248 | 0 | 891 | 643 to 891 (+38.57 %) |
Jan 05 2021 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Option Exercise | A | 482.68 | 3,613 | 1,743,923 | 3,613 | |
Jan 05 2021 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Grant | A | 0.00 | 248 | 0 | 2,078 | 1.8 K to 2.1 K (+13.55 %) |
Jan 05 2021 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | A | 0.00 | 620,270 | 0 | 620,270 |